Connecting biopharmas with the right preclinical cancer models and CRO partners
Helping you find the right data
We’re analysing and labelling human genomic data from sources big and small. So it’s easy to find, compare and share.
Current drug discovery landscape is complex
There is a phenotypic approach to cancer, a growing acceptance of defining cancer by their molecular phenotype
Modern drug discovery is a data-driven process and relies heavily on precision medicine approaches
Translation from preclinical trials to the clinic is notoriously low with 95% failure in oncology drug discovery
A manual ad-hoc approach for search is not enough
Team up with Repositive's expertise
Repositive is a human-centred organization where a team of mission-driven scientists, bioinformaticians, and developers meet to create a future of better treatments.
We will help you find the most suitable preclinical cancer model for your study.
Benefit from Repositive’s specialised expertise in seeking out specific models to match your needs
We have developed a worldwide partner network of CROs providing cancer models and services
Our partner CROs list their models in our standardised inventory on our cancer models platform